Dow Jones and S&P500 rise as Trump's softer tariff tone eases trade fears. 3M, Moderna lead sector gains, while Apple dips on weak AI outlook.
The headline numbers for 3M (MMM) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
3M (MMM 1.33%), the global conglomerate known for its innovative products in diverse sectors like healthcare and consumer goods, reported fourth-quarter earnings on Tuesday, Jan. 21, that topped analyst estimates. Adjusted earnings per share (EPS) of $1.68 slightly exceeded the analyst consensus of $1.66.
3M has had a busy year with its second quarter, marking a fresh start of sorts for the 122-year-old company.
3M reports earnings per share of $1.68 from sales of $6 billion. Wall Street was looking for earnings of $1.66 from sales of $5.8 billion.
3M (MMM 1.33%) probably isn't going to make the average investor a millionaire. Nevertheless, the potential for significant long-term returns exists, contingent on management's successful restructuring for growth.
As MMM gears up to report fourth-quarter earnings, let us find out how the expectations stack up and whether it is the right time to buy, hold or sell the stock.
3M Co. MMM will release its fourth-quarter financial results, before the opening bell, on Tuesday, Jan. 21, 2025.
3M (MMM -0.27%) stock is rebounding off the lows, but that doesn't mean it cannot be undervalued.
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for 3M (MMM), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2024.
3M (MMM 0.38%) made strategic changes to the business that are bearing fruit.